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Objectives The purpose of this study was to describe hospital variability in the rate of finding obstructive coronary ar-
tery disease (CAD) at elective coronary angiography.
Background A recent national study found that obstructive CAD was found in less than one-half of patients undergoing
elective coronary angiography.
Methods We performed a retrospective analysis of 565,504 patients without prior myocardial infarction or revascu-
larization undergoing elective coronary angiography using CathPCI Registry data from 2005 to 2008 to
evaluate the rate of finding obstructive CAD (any major epicardial vessel stenosis 50%) at coronary an-
giography at 691 U.S. hospitals.
Results The rate of obstructive coronary disease found at elective coronary angiography varied from 23% to 100%
among hospitals (median 45%; interquartile range: 39% to 52%), and were consistent from year to year
and when alternative definitions of coronary stenosis were applied. Sites with lower rates of finding obstruc-
tive CAD were more likely to perform procedures on younger patients, those with low Framingham risk
(33% in lowest yield quartile vs. 21% in highest yield quartile, p  0.0001); with no or atypical symptoms
(73% vs. 58%, p  0.0001); and with a negative, equivocal, or unperformed functional status assessment.
Hospitals with lower rates of finding obstructive CAD also less frequently prescribed aspirin, beta-blockers,
platelet inhibitors, and statins (all p  0.0001). The CAD rate was lower at facilities with small-volume
catheterization laboratories and was not associated with hospital ownership or teaching program status.
Conclusions The rate of finding obstructive CAD at elective coronary angiography varied considerably among reporting cen-
ters and was associated with patient selection and pre-procedure assessment strategies. This institutional
variation suggests that an important opportunity may exist for quality improvement. (J Am Coll Cardiol
2011;58:801–9) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.05.019Diagnostic invasive coronary angiography is an important tool
for identifying those patients with obstructive coronary disease
who may benefit from coronary revascularization. However,
this procedure has associated costs, exposes patients to radia-
tion, and has a small but well-described risk for procedural
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accepted May 3, 2011.complications. As such, the decision to perform coronary
angiography should be selective and ideally limited to patients
with moderate to high pre-test probability for obstructive
coronary artery disease (CAD) (1,2). A recent national study
found that less than one-half of patients undergoing elective
coronary angiography had obstructive CAD (3). However,
previous studies have not investigated the degree to which
the finding of obstructive CAD varies among centers nor
the potential correlates of variation, if it exists. Such
investigation is important, as several groups have proposed
that using centers’ rate of finding of obstructive CAD at
coronary angiography may be a potential quality metric
(4–6). Additionally, identification of providers with a con-
sistently lower rate of finding obstructive disease may offer
an opportunity for improving quality and efficiency of
cardiac care.
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Variability in Finding Obstructive CAD at Catheterization August 16, 2011:801–9We analyzed data in the Na-
tional Cardiovascular Data Regis-
try (NCDR) CathPCI Registry to
determine variation in hospitals’
rate of finding obstructive CAD at
elective coronary angiography per-
formed in patients without known
CAD. We also examined patient
and hospital predictors of this rate,
as well as temporal trends and
stability of these measures over time.
Methods
Data source. The CathPCI Registry, sponsored by the
merican College of Cardiology (ACC) and the Society
or Cardiovascular Angiography and Interventions
SCAI), is a large, ongoing registry of clinical data and
rocedural outcomes associated with diagnostic cardiac
atheterization and percutaneous coronary intervention
PCI) derived from more than 1,000 participating sites
cross the United States (7). Data are captured by
NCDR-certified databases at participating hospitals and
include patient and hospital characteristics, procedural
findings, interventions, and outcomes based on explicit
data elements pre-specified by an NCDR committee (8).
All data were collected using version 3 of the data
collection form. An auditing program ensures the validity
of the collected data; only institutions whose submissions
meet quality criteria for data reporting are included. The
institutional review board of the Duke University Health
System approved this study as exempt from formal
review.
Study population. From the overall CathPCI Registry
cohort, only patients without a previous diagnosis of CAD
who were undergoing elective coronary angiography were
identified. We specifically excluded patients with prior
history of myocardial infarction, PCI, coronary artery bypass
surgery, cardiac transplant, or valve surgery. We also ex-
cluded those whose procedure was classified as emergent or
urgent indications, such as acute coronary syndromes, acute
myocardial infarction, and those in whom their catheteriza-
tion may not have been done to “rule out” CAD, such as
evaluations before transplant or valvular surgery or cardio-
myopathy evaluation. Finally, to assure more stable esti-
mates of site performance, we excluded sites with low
numbers (i.e., 50 cases) of elective diagnostic cardiac
catheterization per year (Fig. 1).
Patient characteristics and definitions. Patient demo-
graphics, clinical risk factors, symptom status, and non-
invasive test findings were collected as specified in the
NCDR registry. Patient symptoms were categorized as
no symptoms/no angina, atypical chest pain, or stable
angina. Atypical chest pain was defined as pain, pressure,
or discomfort in the chest, neck, or arms not clearly
Abbreviations
and Acronyms
ACC  American College of
Cardiology
CAD  coronary artery
disease
MI  myocardial infarction
PCI  percutaneous
interventionexertional or not otherwise consistent with pain ordiscomfort of myocardial ischemic origin. Stable angina
was defined as angina without a change in frequency or
pattern for 6 weeks before the catheterization laboratory
visit. Sites recorded if a noninvasive diagnostic test was
performed “to rule out ischemia prior to the procedure
either during that visit or prior to that visit.” Noninvasive
tests were defined to include “[electrocardiography], ex-
ercise or pharmacologic stress tests, radionucleotide,
echo, [computed tomography] scans or other heart scans”
(8). The results of these tests were categorized as positive,
negative, or equivocal.
For the purpose of the primary analysis, obstructive CAD
was defined as being present in patients with50% stenosis
in any major epicardial vessel or branch vessel 2.0 mm in
diameter in accordance with the ACC/American Heart
Association coronary artery bypass grafting surgery practice
guideline 2004 update (9) and that is associated with a
fractional flow reserve of 0.80 in 63% of patients (10).
Alternate definitions of obstructive CAD that included any
lesion 70% stenosis (50% left main) and 20% stenosis
ere used for a sensitivity analysis. Determination of the
egree of stenosis was made by site physicians. Data
egarding possible fractional flow reserve were not available.
Figure 1 Population Flow Diagram
Flow diagram showing the process used to define the study population. ACS 
acute coronary syndrome; AMI  acute myocardial infarction; CABG  coronary
artery bypass surgery; CAD  coronary artery disease; cath  catheterization;
lab  laboratory; MI  myocardial infarction; PCI  percutaneous coronary
intervention; r/o  rule out; Sx  symptoms.
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August 16, 2011:801–9 Variability in Finding Obstructive CAD at CatheterizationHospital characteristics and definitions. Hospital charac-
teristics were determined from the site profile information
supplied by each institution to NCDR using standardized
data definitions. These included several measurements of
size, including the number of inpatient beds and annual
volumes of diagnostic catheterizations, PCI, and electro-
physiology studies. The presence or absence of an onsite
cardiac surgery program was recorded. Administrative data
included geographic region, ownership or profit type (pri-
vate, university, or government), and setting (urban, rural,
or suburban). Additional data included the presence of a
teaching program, inclusion as a clinical trial site, and years
of NCDR participation.
Statistical analysis. The rate of finding obstructive CAD
was calculated for each hospital by quarter and overall.
Demographics, risk factors, symptom status, and nonin-
vasive test findings were compared across hospitals by
quartiles of overall rate of finding obstructive CAD.
Continuous variables are presented as medians; categor-
ical variables are presented as percentages. Kruskal-
Wallis tests were used for continuous variables, and
Pearson chi-square tests were used for categorical vari-
ables in all descriptive tables.
The stability of each hospital’s diagnostic yield over time
was tested by fitting a linear mixed-effects regression model
clustering on hospital with a fixed effect for time in quarters
(11). Rates over time were allowed to vary randomly across
institutions; this appropriately fit our data as well as allowed
us to make inferences about the population of institutions.
Unbiased estimates of variance parameters were obtained by
fitting the model using restricted maximum likelihood (12).
In addition, a “sensitivity analysis” was performed by com-
paring results of a mixed-effects model with both random
intercepts and slopes and to another mixed-effects model
with only random intercepts. The model with both random
intercepts and slopes provided the best fit based on Akaike
information criterion and was used in the analysis. Annual
trends were assessed using Spearman rank correlations of
hospital median annual yield for consecutive years. Spear-
man rank correlations were also used to determine the
association between diagnostic yields for different cut points
of CAD.
Individual patient risk was estimated separately by
applying a previously published logistic regression model
with generalized estimating equations to predict patient
likelihood of having obstructive CAD (3). The variables
in this model are presented in Table 1 (patient-level
variables). Hospital-level variables (Table 2) were candi-
dates in this previously published model, but were ex-
cluded from the final model due to lack of association
with obstructive CAD. Within each hospital, median
predicted patient risk was calculated as a summary of
patient risk at that hospital.
A value of p  0.05 was considered significant for all
tests. All statistical analyses were performed by the DukeClinical Research Institute using SAS software (version 9.2,
SAS Institute, Cary, North Carolina).
Results
From 2005 to 2008, 565,504 patients were treated at 691
CathPCI Registry participating centers and met criteria
(Fig. 1). Reported rates of obstructive CAD varied among
hospitals from 23% to 100%, with a median of 45% and an
interquartile range of 39% to 52% (Fig. 2). Ninety-one
hospitals (13%) had diagnostic yields 35%, whereas 82
had diagnostic yields 75%. The overall rate of finding
obstructive CAD was constant over time at 44.4% in 2005
and 45.6% in 2008 (p  0.90 for time trend). Individual
hospital rates were also stable over time, with high correla-
tion in year-to-year individual hospital performance: rho 
0.72 (2005 vs. 2006) and rho  0.73 (2006 vs. 2007), both
p  0.0001.
Characterization of sites with low versus high rates of
finding obstructive CAD. Relative to those institutions in
the highest quartile rate of finding obstructive CAD, those
with the lowest rates performed coronary angiography more
often in younger patients, women, blacks, and outpatients
(all p  0.001) (Table 1). Similarly, those centers with the
lowest rates studied patients with lower Framingham risk
(33% vs. 21%, p  0.0001), with atypical symptoms (45%
vs. 27%, p  0.0001), and a negative, equivocal, or not
performed functional status assessment (33% vs. 29%, p 
0.0001) compared with the highest quartile. Patients stud-
ied at low-rate centers were also less likely to have stable
angina symptoms (27% vs. 42%) or a positive stress test
before coronary angiography (66% vs. 71%), both p 
0.0001. Patients treated by hospitals with low rates of
finding obstructive CAD were less likely to have been
prescribed cardiac medications before angiography (aspirin,
beta-blockers, platelet inhibitors, or statins, all p  0.0001).
Other hospital characteristics significantly associated with a
low CAD rate in univariate analyses included smaller
hospitals and those with lower annual interventional labo-
ratory volumes. CAD rates were higher in the West and at
clinical trial sites, whereas teaching program presence,
ownership (private vs. university), and setting did not differ
across CAD rate strata.
As a summary of the relationship between patient risk
and the rate of finding obstructive CAD, we applied a
previously published logistic regression model based on data
elements in CathPCI (3) incorporating Framingham risk
score, other clinical variables, chest pain characteristics, and
noninvasive testing results to predict patient likelihood of
having obstructive CAD and compared this with the actual
rate at each institution. Hospitals with the lowest rate of
CAD had only a 39% median predicted likelihood for
obstructive CAD versus 55% in the highest quartile rate of
CAD (p  0.0001). Furthermore, the median predicted
patient likelihood of having obstructive CAD at each
institution was significantly correlated with the actual me-
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Variability in Finding Obstructive CAD at Catheterization August 16, 2011:801–9Characteristics of Patients Undergoing Elective Diagnostic Cardiac CatheterizationStr tified by Hospital Quartiles of Rates of Finding Obstru tive CADTable 1 Characteristics of Patie ts Undergoing Elec ve Diagnostic Card ac CatheterizationStratified by Hospital Quartiles of Rates of Finding Obstructive CAD
Hospital Quartile of CAD Rate, All Sites
(n  691)
Hospital Quartile of CAD Rate
Excluding Sites With CAD >90%
(n  619)
1
(Lowest)
(n  172)
2
(n  173)
3
(n  173)
4
(Highest)
(n  173)
p Value
Comparing
1, 2, 3, 4
Revised 4*
(n  101)
p Value Comparing
1, 2, 3,
Revised 4*
Range of CAD rate 23–39 39–45 45–52 52–100 52–86
Median CAD rate 35 42 48 70 57
Patients, n (N  565,504) 162,211 178,963 139,466 84,864 62,263
Demographics
Median age, yrs 60 61 62 64 0.0001 63 0.0001
Female 51 49 45 41 0.0001 42 0.0001
Race/ethnicity
White, non-Hispanic 81 83 78 83 0.0001 82 0.0001
Hispanic 3 3 5 5 5
Black 11 9 8 6 6
Asian/Native-American 1 1 2 3 3
Outpatient 73 70 69 54 0.0001 62 0.0001
Clinical risk factors
BMI, kg/m2 29.9 29.8 29.4 29.1 0.0001 29.1 0.0001
Tobacco use
Current 22 20 17 17 0.0001 16 0.0001
Former 29 33 32 35 35
Never 49 47 50 48 49
Diabetes
Any 26 26 26 27 0.0001 27 0.2018
Insulin 7 6 7 7 6
Hypertension 70 70 70 74 0.0001 73 .0001
Prior CHF 4 4 5 4 0.6603 5 0.1180
Family history of CAD 29 30 29 27 0.0001 27 .0001
Dyslipidemia 59 62 64 71 0.0001 69 0.0001
Creatinine clearance, ml/min 68.7 67.8 67.0 66.3 0.0001 66.5 0.0001
Peripheral vascular disease 7 7 7 8 0.0001 7 0.0001
Cerebrovascular disease 7 7 7 7 0.0001 7 0.0001
Chronic obstructive lung disease 17 15 13 13 0.0001 13 0.0001
Medication use
ASA 66 72 73 81 0.0001 78 0.0001
Beta-blocker 38 41 44 50 0.0001 50 0.0001
Platelet aggregation inhibitor 16 19 24 45 0.0001 33 0.0001
Statin 35 39 42 49 0.0001 48 0.0001
Risk stratification
Median (IQR) predicted patient likelihood
of having obstructive CAD
39 (23–57) 44 (29–58) 48 (35–58) 55 (33–69) 0.001 52 (33–69) 0.0001
Framingham risk
Low 33 29 27 21 0.0001 23 0.0001
Medium 53 55 56 58 57
High 14 16 17 21 20
Clinical symptoms
None 28 30 34 31 0.0001 32 0.0001
Atypical 45 36 33 27 29
Stable angina 27 33 34 42 40
Noninvasive testing
Not performed 16 14 18 17 0.0001 18 0.0001
Negative 14 13 10 9 8
Equivocal 3 4 4 3 3
Positive 66 69 68 71 70Continued on the next page
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Hospital Quartile of CAD Rate, All Sites
(n  691)
Hospital Quartile of CAD Rate
Excluding Sites With CAD >90%
(n  619)
1
(Lowest)
(n  172)
2
(n  173)
3
(n  173)
4
(Highest)
(n  173)
p Value
Comparing
1, 2, 3, 4
Revised 4*
(n  101)
p Value Comparing
1, 2, 3,
Revised 4*
Nonclinical predictors
Insurance status
None 5 3 4 3 0.0001 3 0.0001
Government 44 44 44 45 44
Commercial 42 39 35 37 37
HMO 9 15 18 15 15Values are % unless otherwise noted.
ASA  acetylsalicylic acid; BMI  body mass index; CAD  coronary artery disease; CHF  congestive heart failure; HMO  health maintenance organization; IQR  interquartile range.Hospital Characteristics Stratified by Quartiles of Rates of Finding Obstructive CAD at Elective CatheterizationTable 2 Hospital Characteristics Stratified by Quartiles of Rates of Finding Obstructive CAD at Elective Catheterization
Hospital Quartile of CAD Rate
All
(N  691)
1
(Lowest)
(n  172)
2
(n  173)
3
(n  173)
4
(Highest)
(n  173) p Value
Range of CAD rate, % 23–39 39–45 45–52 52–100
Median CAD rate, % 45 35 42 48 70
Size/capabilities
Inpatient beds
Median (25th, 75th) 335 (235, 461) 305 (221, 447) 350 (241, 491) 313 (215, 415) 383 (265, 511) 0.0008
Mean  SD 371 202 346 184 384 194 329 173 424 240
Diagnostic cath volume (annual)
Median (25th, 75th) 1,374 (825, 2,200) 1,360 (842, 2,308) 1,400 (800, 2,287) 1,197 (740, 1,821) 1,500 (1,000, 2,404) 0.0618
Mean  SD 1,729 1,369 1,762 1,296 1,755 1,409 1,421 1,055 1,979 1,608
PCI volume (annual)
Median (25th, 75th) 490 (268, 795) 422 (216, 728) 499 (273, 761) 401 (234, 640) 646 (382, 1,003) 0.0001
Mean  SD 612 513 562 510 587 467 496 382 802 617
EP study volume (annual)
Median (25th, 75th) 72 (0, 206) 50 (0, 158) 83 (0, 195) 50 (0, 162) 123 (25, 337) 0.0001
Mean  SD 174 320 134 275 175 375 138 279 250 330
On site cardiac surgery, % 81 78 80 79 87 0.1555
Administrative
Geographic location, %
Northeast 13 8 14 19 13 0.0063
South 35 48 32 31 32
Midwest 32 31 35 28 34
West 19 13 19 21 21
Ownership/profit type, %
Private/community 90 88 89 93 88 0.8822
University 9 9 9 6 10
Government 2 2 2 1 2
Setting, %
Urban 51 53 50 43 58 0.0828
Rural 18 20 20 20 13
Suburban 31 27 30 37 29
Teaching program, % 44 40 46 41 48 0.3996
Clinical trial site, % 32 26 34 26 43 0.0009
Years of NCDR participation
2 25 24 21 25 31 0.1269
2–3 72 73 75 71 69CAD  coronary artery disease; cath  catheterization; EP  electrophysiology; NCDR  National Cardiovascular Data Registry; PCI  percutaneous coronary intervention.
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Variability in Finding Obstructive CAD at Catheterization August 16, 2011:801–9dian finding of obstructive CAD at that institution (Spear-
man rho  0.71, p  0.0001).
As a sensitivity analysis, we changed the definition of
CAD to include either more severe or milder lesions and to
account for possible slight site variation in classification of
lesion severity. As expected, varying this definition progres-
sively shifted the distribution of CAD rates such that if the
cut point for CAD was redefined as any lesion 70%
stenosis (or 50% left main), the median CAD rate fell to
37%, but if set at 20%; the median rate was 61% (Fig. 2).
However, there remained a similar, wide variation in
hospital obstructive CAD rate at coronary angiography,
regardless of what definition was used. In addition, using
different definitions of CAD did not alter institutional
rankings: rho  0.96 for comparison of 70% with
50%, rho  0.83 for comparison of 50% with 20%,
and rho  0.76 for comparison of 70% with 20% cut
points (all p  0.0001) (Fig. 3). Finally, to investigate
otential under-reporting of normal coronary angiogra-
hy findings by high-yield sites, we removed the data
rom the 72 sites with a 90% rate of finding CAD and
ecalculated patient characteristics by quartile, but our
ndings were essentially unchanged (see Table 1 for
ecalculated quartile 4* descriptors and p values).
odeling the potential impact of altering hospital ob-
tructive CAD rates. Given the degree of hospital vari-
bility, we sought to investigate what could be the potential
mpact if a CAD evaluation and coronary angiography
eferral strategy similar to that of centers with the highest
AD rates could be applied to systems with lower rates.
Figure 2 Impact of Using Varying Cut Points of Coronary Artery
to Define Rate of Finding Obstructive CAD at Elective
Distribution of hospitals’ rates of finding coronary artery abnormalities using differ
any lesions 70% stenosis; any lesions 50% stenosis; any lesions 20% stenopecifically, the highest quartile hospitals had a median rate sf finding obstructive CAD of 70%. If this rate could be
chieved by all institutions in the study, the number of
atients undergoing coronary angiography in quartiles 1
hrough 3 and found not to have obstructive CAD could be
educed by 70% (from 281,758 to 85,235). If the CAD rate
f the lowest 2 quartiles of centers were to increase to the
edian U.S. performance (45%), then the number of
atients without obstructive disease undergoing coronary
ngiography in these hospitals would be reduced by 23%,
rom 209,236 to 161,258.
iscussion
o our knowledge, this is the first study to examine
ospital-level variability and its predictors in the rate of
nding obstructive CAD at elective, diagnostic coronary
ngiography. Our study found marked variation in the
nstitutional rate of finding obstructive CAD among pa-
ients undergoing elective diagnostic cardiac catheterization,
hich was stable over time at each center. This variation
as predictable based on the characteristics of the patients
elected for the procedure and their pre-catheterization
valuation, testing, and treatment. Centers with a low rate
f finding obstructive CAD undertook procedures on pa-
ients who were younger, had a lower likelihood of disease,
nd who were less likely to have had a noninvasive evalua-
ion demonstrating ischemia before coronary angiography.
inally, modeling suggests that up to one third of elective,
iagnostic cardiac angiograms might not be required if low
AD rate centers were able to adopt similar patient
ormalities
iography
t points to define abnormal. Cut points used are as follows:
ny lesions 0% stenosis. CAD  coronary artery disease.Abn
Ang
ent cu
sis; aelection, treatment, and testing patterns as currently prac-
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August 16, 2011:801–9 Variability in Finding Obstructive CAD at Catheterizationticed in those institutions with the highest rates of finding
CAD.
The robustness of an assessment of the institutional rate
of finding obstructive CAD in patients undergoing elective
diagnostic coronary angiography is supported by several
factors. First, although our definition of obstructive CAD
was based on the finding of any stenosis 50%, sensitivity
analysis found that even if we varied the diagnostic thresh-
old for CAD from 20% to 70%, the relative hospital
performance rankings were quite constant (Fig. 3). Second,
the association between patients’ predicted likelihood for
disease in each hospital and that actually found supports
that these findings are real as opposed to artifactual. Finally,
the consistency in the degree of variability in hospital CAD
year in and year out may help to partially allay concerns that
Figure 3
Sensitivity of Each Institution’s Obstructive CAD
Rate to Varying Cut Points of Coronary Artery
Abnormalities
(A) Comparison of any lesion 50% versus 70% cut point (rho  0.96,
p  0.0001); (B) comparison of 20% versus 50% cut point (rho  0.83,
p  0.0001). CAD  coronary artery disease.sites may vary what they self-report as a percentage stenosis uor may underreport results of diagnostic procedures in favor
of PCI.
Prior studies examining anatomic findings at diagnostic
coronary angiography in patients without known CAD have
used varying cut points, sometimes assessing obstructive
CAD and sometimes assessing its absence. Comparison of
these studies is further plagued by the use of varying cut
points, with “normal” coronaries sometimes including pa-
tients with stenoses as high as 30% or even 50%. In the few
studies providing information regarding rates of finding
obstructive CAD at elective diagnostic angiography, rates as
high as 88% (13) and as low as 57% (14) have been reported.
In CASS (Coronary Artery Surgery Study), 3,136 of 21,487
consecutive angiograms (14.6%) were “entirely normal”
(15), and 4,051 (81%) showed stenosis50%. Furthermore,
these studies and current NCDR benchmarking efforts do
not always exclude those with known CAD (i.e., prior
myocardial infarction or revascularization) from their co-
horts (4) or those with acute coronary syndromes, both of
which can substantially increase the CAD rate. This serves to
obscure the outcome of decision making in the subset of
interest—elective patients without known disease—for
whom the decision to proceed to angiography is an impor-
tant clinical process.
The rate of finding obstructive CAD may be related to
both the appropriateness of the procedure, which in turn
may be related to the population utilization. Substantial
variation in population utilization rates can be noted, even
among Western countries, ranging from 83 per 10,000 in
the United States to 12 per 10,000 in the Netherlands (16).
n the United States, geographic variation in diagnostic
ngiography rates are often not tracked or reported, unlike
ngioplasty and bypass surgery rates, although they may also
e expected to show similar variation (17). Few recent
ssessments of the appropriateness of angiography have
een performed in the United States; in a study published in
987, Chassin et al. (18) noted 72% to 81% appropriateness
nd 17% inappropriateness. More recently, in the United
ingdom, with a population rate of 26 catheterizations per
0,000, 62% of diagnostic angiograms were rated as appro-
riate, 33% uncertain, and 5% inappropriate (19). Some
uthors have noted that coronary angiography may be
verutilized due to factors such as an abundance of cathe-
erization facilities, a surplus of interventional cardiologists,
nd monetary reimbursement to physicians (20), whereas
thers note the role of patient, family, and colleagues’
xpectations as well as fear of liability as important contrib-
tors to the propensity to order these procedures (21).
lthough these population studies and determination of
ppropriateness shed light on patterns of utilization, the rate
f finding obstructive CAD provides a powerful clinical
orrelation between angiogram performance and disease
resence, an important patient outcome.
The finding that hospital variation in performance was
ot random suggests that there may be opportunities to
tilize different patient selection criteria at institutions
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angiography. Indeed, the parameters most powerfully
associated with finding CAD are those well known to be
predictive of CAD, including advancing age, male sex,
risk factors, and typical symptoms. Patients undergoing
angiography in the lowest rate hospitals were more likely
to have a low Framingham risk score, atypical symptoms,
and a normal noninvasive test result. Although our data
cannot indicate what the ideal or “optimal” CAD rate is
for elective coronary angiography, these associations
suggest that improved patient selection could increase the
rate of finding CAD in these institutions. Consistent use
of clinical risk stratification algorithms (3) and improve-
ment in the use, accuracy, and quality of pre-procedural
noninvasive testing, and perhaps future coronary angiog-
raphy appropriate-use criteria, may help raise the rate of
finding obstructive CAD.
The finding of stability of each hospital’s rate over time
suggests that it is reflective of the system rather than
individual providers. This makes clinical sense, as 1 or
several providers may be involved in the sequential
decisions to pursue a diagnostic coronary angiogram,
beginning with the provider that first began the search for
coronary disease, the provider who performed and inter-
preted a pre-procedural noninvasive test, the referring
provider (who recommended an invasive procedure), and
the catheterization laboratory physician. Each of these
individuals and decisions may be influenced by many
factors, including the need for a definitive diagnosis, even
if it is the exclusion of CAD; patients’ and families’
expectations; and the potential legal impact of not
performing the “gold standard” study. Thus, the system
rate of finding obstructive CAD may offer a way to assess
the overall process by recognizing the end result of the
process of diagnostic evaluation of CAD in patients
under its care.
Study strengths and limitations. The NCDR is a large,
national, real-world data registry, which uniquely represents
contemporary clinical practice in the community. Building
on this strength, our analysis provides current information
on the frequency of an important outcome of diagnostic
coronary angiography, the rate of finding obstructive coro-
nary disease during elective diagnostic coronary angiography
in a broad sample of U.S. hospitals. We cannot address the
appropriateness of the decision to proceed to coronary
angiography; our use of a registry database precludes de-
tailed knowledge of clinical circumstances and decision-
making process or of long-term clinical outcomes. Similarly,
we are unable to address the possibility of any underuse of
coronary angiography by sites with too high a threshold for
performing the procedure. Further, the accuracy of this
analysis depends on the accuracy of site coding for the
indication for the procedure, patient symptoms and risk
factors, noninvasive testing, and severity of coronary steno-
ses. Significant details are not available, including those
regarding the pre-catheterization evaluation, such as sever- hity of symptoms and risk factors; the type of noninvasive
testing utilized; and the extent and severity of ischemia on
noninvasive testing; as well as the physiological significance
of intermediate lesions, the intensity or optimization of
medical therapy, or individual operator data. Finally, in the
absence of any information regarding patients not undergo-
ing cardiac catheterization, we are unable to assess the
accuracy or value of risk stratification or diagnostic testing in
guiding the decision to proceed to catheterization, as there
would be substantial verification/selection bias inherent in
our cohort.
Implications for potential use of rate of finding obstructive
CAD at elective diagnostic cardiac catheterization in quality
improvement. Although assessment of the institutional
rate of finding CAD has been encouraged by ACC/SCAI
and other entities as an important step in assessing quality of
care and integral to efforts to improve it, in the absence of
national data, it has not been previously explored (4–6).
Most current, well-established catheterization laboratory
quality metrics focus on angioplasty, for which complication
rates are often used to assess quality. However, given the
very low frequency of such complications associated with
diagnostic catheterization, other parameters may be needed
to contribute to the assessment of quality. Similarly, recom-
mendations for patient selection for catheterization have
focused on the American College of Cardiology Foundation
Appropriate Use Criteria for Revascularization (4,9) and to
date have not addressed diagnostic coronary angiography
diagnostic procedures.
Quality assessment should be evidence-based, measur-
able, interpretable, linked to outcomes, and actionable (22).
he extent to which the rate of diagnosing coronary stenosis
eets these characteristics would indicate its suitability for
otential initial voluntary use for internal feedback and
mprovement. Indeed, quality metrics are defined by the
CC/American Heart Association as “those measures that
ave been developed to support self-assessment and quality
mprovement at the provider, hospital, and/or health system
evel” (23). Before broader application can be recom-
ended, further definition, research, field testing, and
perational consideration would be needed (22). For exam-
le, as noted previously, the optimal CAD rate is unclear.
edical-legal concerns, patient and family preferences, the
ncontrovertible value of excluding CAD in a symptomatic
atient, microvascular disease (23–25), and the roughly 10%
ate of normal coronary arteries in ST-segment elevation
yocardial infarction patients (26) make the elimination of
ll cases without obstructive CAD both impractical and
ndesirable. However, because obstructive coronary disease
s associated with patient symptoms (angina) that can be
elieved with revascularization (9), it is generally reasonable
o conclude that improving the CAD rate would be good for
atients by avoiding exposure to costly invasive procedures
n those who are unlikely to benefit from revascularization.
ndeed, our modeling of the potential impact of improving
ospital CAD rates to optimal or even median levels
11
1
1
1
1
1
1
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phy in patients without obstructive CAD, between 12% and
24%, might result.
Conclusions
There is significant interhospital variation in the rate of
finding obstructive CAD in patients undergoing elective,
diagnostic coronary angiography to exclude significant
CAD. The institutional CAD rate was associated with
baseline cardiac risk, chest pain characteristics, noninvasive
test performance and results, and intensity of pre-procedural
medical therapy, but there were few relationships with
nonclinical or institutional factors. This suggests that local
clinical practice patterns may be the most influential factor
in guiding use of diagnostic coronary angiography and could
be a target for quality-improvement efforts, including ap-
propriate use criteria development. A balanced consider-
ation of all the relevant steps inherent in a decision to
proceed to elective invasive coronary angiography, as well as
the finding of CAD at catheterization, is needed to opti-
mize coronary angiography utilization.
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